← Research library

Efficacy and possible mechanisms of action of Selank in generalized anxiety disorders and neurasthenia

Randomized study in people · 2008

What was studied
62 patients; treatment-arm counts conflict between indexed abstract (30/32) and abridged reprint (42/20)
Main finding
The authors report similar anxiety changes with the two treatments and assess serum enkephalin metabolism.

Reported findings and study design

62 patients with generalized anxiety disorder or neurasthenia. Indexed abstract: Selank 30, medazepam 32.

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Anxiety outcomeSimilar changes reportedNo numerical scale change supplied
Treatment-arm counts in an abridged reprint42 and 20Conflicts with the indexed 30/32 split

The arm discrepancy is unresolved. The figures describe diagnostic groups. Treatment-group sizes are separate.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Original journal version needed to resolve treatment-arm discrepancy. The 30 anxiety and 32 neurasthenia cases are diagnostic groups. Treatment-group sizes are separate.
  • Allocation concealment and blinding remain unresolved.
  • Active-comparator similarity does not establish noninferiority or long-term safety.

Source details

Journal publication · Indexed abstract plus abridged commercial-hosted reprint

Indexed abstract and branded-site abridged PDF methods checked. The PDF explicitly states it is shortened; it is not the complete original article.

Abstract and selected reprint methods; source discrepancy

Sources checked

Citation

Randomized trialEnglish abstract

A A Zozulia, G G Neznamov, T S Siuniakov, N V Kost, M V Gabaeva, O Iu Sokolov, E V Serebriakova, O A Siranchieva, A V Andriushenko, E S Telesheva, S A Siuniakov, A B Smulevich, N F Miasoedov, S B Seredenin. Efficacy and possible mechanisms of action of Selank in generalized anxiety disorders and neurasthenia Zh Nevrol Psikhiatr Im S S Korsakova. 108(4):38–48

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards